Skip to main content

Table 3 Factors associated with proximal deep vein thrombosis

From: Incidence of proximal deep vein thrombosis in medical critical care patients

Characteristic

No DVT

(133)

DVT

(25)

p

Multivariable analysisa

Adjusted OR

(95% CI)

p

Age, median (IQR), years

61

(45-75)

72

(64-80)

0.04

1.04b (1.01-1.07)

0.02

Female sex, n (%)

59

(44.4)

17

(68)

0.051

4.05 (1.51-12.3)

0.01

BMI, median (IQR), kg/m2

21.6

(19-24.2)

21.3

(19.2-24.4)

0.83

  

Acute conditions, n (%)

     

Acute respiratory failure

107 (80.5)

22 (88)

0.57

  

Sepsis

104 (78.2)

20 (80)

0.99

  

Acute kidney injury

37 (27.8)

7 (28)

0.99

  

Congestive heart failure

9 (6.8)

2 (8)

0.69

  

COPD with acute exacerbation

8 (6)

2 (8)

0.66

  

Cerebrovascular accident

9 (6.8)

0 (0)

0.36

  

ARDS

8 (6)

1 (4)

0.99

  

APACHE II, mean (SD), points

20.8 (7.7)

22.3 (5.7)

0.26

  

History of cancer, n (%)

22 (16.5)

3 (12)

0.77

  

History of previous VTE, n (%)

1 (0.8)

1 (4)

0.29

  

RRT, n (%)

17 (12.8)

8 (32)

0.03

  

Duration of RRT, median (IQR), days

2 (1-19)

6.5 (2.5-13.3)

0.68

  

Platelet transfusion, n (%)

27 (20.3)

1 (4)

0.08

0.07 (0.003-0.43)

0.02

Use of vasopressor or inotropes, n (%)

89 (66.9)

18 (72)

0.79

  

Use of NMBA, n (%)

18 (13.6)

6 (24)

0.22

  

Central venous line, n (%)

68 (51.1)

17 (68)

0.18

  

Internal jugular vein

59 (44.4)

14 (56)

0.94

  

Femoral vein

15 (11.3)

9 (36)

0.004

11.18 (3.19-44.83)

< 0.001

Subclavian vein

5 (3.8)

3 (12)

0.11

  

Cubital vein

8 (6)

1 (4)

0.99

  

Mechanical ventilation, n (%)

111 (83.5)

22 (88)

0.77

  

Clinical probability at first 48 h,

n (%)

     

Low

106 (79.7)

15 (60)

0.02

  

Moderate

23 (17.3)

6 (24)

   

High

4 (3)

4 (16)

   
  1. APACHE = acute physiology, age, chronic health evaluation, ARDS = acute respiratory distress syndrome, BMI = body mass index, CI = confidence interval, COPD = chronic obstructive pulmonary disease, DVT = deep vein thrombosis, IQR = interquartile range, NMBA = neuromuscular blocking agent, OR = odds ratio RRT = renal replacement therapy, VTE = venous thromboembolism
  2. aArea under the receiver operating characteristic curve (95% CI) of multivariable analysis = 0.72 (95% CI 0.60–0.85)
  3. bper 1 point increase